Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease.
Mulder SD, Heijst JA, Mulder C, Martens F, Hack CE, Scheltens P, Blankenstein MA, Veerhuis R. Mulder SD, et al. Among authors: heijst ja. Ann Clin Biochem. 2009 Nov;46(Pt 6):477-83. doi: 10.1258/acb.2009.009130. Epub 2009 Sep 3. Ann Clin Biochem. 2009. PMID: 19729499
Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease.
van Dijk KD, Jongbloed W, Heijst JA, Teunissen CE, Groenewegen HJ, Berendse HW, van de Berg WD, Veerhuis R. van Dijk KD, et al. Among authors: heijst ja. Parkinsonism Relat Disord. 2013 Dec;19(12):1079-83. doi: 10.1016/j.parkreldis.2013.07.016. Epub 2013 Aug 6. Parkinsonism Relat Disord. 2013. PMID: 23932065
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
Wessels MH, Van Lierop ZY, Noteboom S, Strijbis EM, Heijst JA, Van Kempen ZL, Moraal B, Barkhof F, Uitdehaag BM, Schoonheim MM, Killestein J, Teunissen CE. Wessels MH, et al. Among authors: heijst ja. Mult Scler. 2023 Sep;29(10):1229-1239. doi: 10.1177/13524585231188625. Epub 2023 Aug 2. Mult Scler. 2023. PMID: 37530045 Free PMC article.
The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women.
Vogelvang TE, Mijatovic V, Kenemans P, Emeis JJ, Heijst JA, van der Mooren MJ. Vogelvang TE, et al. Among authors: heijst ja. Am J Obstet Gynecol. 2005 Oct;193(4):1384-94. doi: 10.1016/j.ajog.2005.02.083. Am J Obstet Gynecol. 2005. PMID: 16202731 Clinical Trial.